These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8119996)

  • 21. Sulfhydryl-alkylating reagents inactivate the NAD glycohydrolase activity of pertussis toxin.
    Kaslow HR; Lesikar DD
    Biochemistry; 1987 Jul; 26(14):4397-402. PubMed ID: 2822091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pertussis toxin S1 mutant with reduced enzyme activity and a conserved protective epitope.
    Burnette WN; Cieplak W; Mar VL; Kaljot KT; Sato H; Keith JM
    Science; 1988 Oct; 242(4875):72-4. PubMed ID: 2459776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Localization of a region of the S1 subunit of pertussis toxin required for efficient ADP-ribosyltransferase activity.
    Cortina G; Barbieri JT
    J Biol Chem; 1991 Feb; 266(5):3022-30. PubMed ID: 1993675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protease treatment of pertussis toxin identifies the preferential cleavage of the S1 subunit.
    Krueger KM; Mende-Mueller LM; Barbieri JT
    J Biol Chem; 1991 May; 266(13):8122-8. PubMed ID: 1850738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pertussis toxin: transition state analysis for ADP-ribosylation of G-protein peptide alphai3C20.
    Scheuring J; Schramm VL
    Biochemistry; 1997 Jul; 36(27):8215-23. PubMed ID: 9204866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenine nucleotides promote dissociation of pertussis toxin subunits.
    Burns DL; Manclark CR
    J Biol Chem; 1986 Mar; 261(9):4324-7. PubMed ID: 3005329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Common features of the NAD-binding and catalytic site of ADP-ribosylating toxins.
    Domenighini M; Magagnoli C; Pizza M; Rappuoli R
    Mol Microbiol; 1994 Oct; 14(1):41-50. PubMed ID: 7830559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computer modelling of the NAD binding site of ADP-ribosylating toxins: active-site structure and mechanism of NAD binding.
    Domenighini M; Montecucco C; Ripka WC; Rappuoli R
    Mol Microbiol; 1991 Jan; 5(1):23-31. PubMed ID: 1901617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation into the catalytic role for the tryptophan residues within domain III of Pseudomonas aeruginosa exotoxin A.
    Beattie BK; Prentice GA; Merrill AR
    Biochemistry; 1996 Dec; 35(48):15134-42. PubMed ID: 8952460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Active-site mutations of diphtheria toxin: effects of replacing glutamic acid-148 with aspartic acid, glutamine, or serine.
    Wilson BA; Reich KA; Weinstein BR; Collier RJ
    Biochemistry; 1990 Sep; 29(37):8643-51. PubMed ID: 1980208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutational, kinetic, and NMR studies of the mechanism of E. coli GDP-mannose mannosyl hydrolase, an unusual Nudix enzyme.
    Legler PM; Massiah MA; Mildvan AS
    Biochemistry; 2002 Sep; 41(35):10834-48. PubMed ID: 12196023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of two site-specifically mutated human dihydrolipoamide dehydrogenases (His-452----Gln and Glu-457----Gln).
    Kim H; Patel MS
    J Biol Chem; 1992 Mar; 267(8):5128-32. PubMed ID: 1347528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetic isotope effect characterization of the transition state for oxidized nicotinamide adenine dinucleotide hydrolysis by pertussis toxin.
    Scheuring J; Schramm VL
    Biochemistry; 1997 Apr; 36(15):4526-34. PubMed ID: 9109661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the active site of ADP-ribosyl cyclase.
    Munshi C; Thiel DJ; Mathews II; Aarhus R; Walseth TF; Lee HC
    J Biol Chem; 1999 Oct; 274(43):30770-7. PubMed ID: 10521467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subunit S1 of pertussis toxin: mapping of the regions essential for ADP-ribosyltransferase activity.
    Pizza M; Bartoloni A; Prugnola A; Silvestri S; Rappuoli R
    Proc Natl Acad Sci U S A; 1988 Oct; 85(20):7521-5. PubMed ID: 2902632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal antibodies that inhibit ADP-ribosyltransferase but not NAD-glycohydrolase activity of pertussis toxin.
    Kaslow HR; Schlotterbeck JD; Kenimer JG
    Infect Immun; 1990 Mar; 58(3):746-52. PubMed ID: 2155182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ADP-ribosylation of alpha i3C20 by the S1 subunit and deletion peptides of S1 of pertussis toxin.
    Finck-Barbançon V; Barbieri JT
    Biochemistry; 1995 Jan; 34(3):1070-5. PubMed ID: 7827022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of cysteine 41 of the A subunit of pertussis toxin.
    Burns DL; Manclark CR
    J Biol Chem; 1989 Jan; 264(1):564-8. PubMed ID: 2535846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A quantitative analysis for the ADP-ribosylation activity of pertussis toxin: an enzymatic-HPLC coupled assay applicable to formulated whole cell and acellular pertussis vaccine products.
    Cyr T; Menzies AJ; Calver J; Whitehouse LW
    Biologicals; 2001 Jun; 29(2):81-95. PubMed ID: 11580213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of histidine 63 in the catalytic mechanism of Bordetella pertussis adenylate cyclase.
    Munier H; Bouhss A; Krin E; Danchin A; Gilles AM; Glaser P; Bârzu O
    J Biol Chem; 1992 May; 267(14):9816-20. PubMed ID: 1577816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.